Prospective observational study of azithromycin in patients with acute exacerbation of fibrosing interstitial pneumonia
Not Applicable
Completed
- Conditions
- acute exacerbation of fibrosing interstitial pneumonia
- Registration Number
- JPRN-jRCT1090220095
- Lead Sponsor
- Dividion of respiratory medicine, Saiseikai Kumamoto Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1) Clinically confirmed acute exacerbation of fibrosing interstitial pneumonia patients in japan based on the JRS diagnostic criteria for acute exacerbation of interstitial pneumonia
2) Patients with written informed consent
Exclusion Criteria
1) Patients with malignancy
2) Patients who have allergy symptoms for macrolide
3) Patient with long QT syndrome or ventricular tachycardia
4) Patients who are not appropriate to participate to the trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 60-day survival from admission
- Secondary Outcome Measures
Name Time Method safety of intravenous azithromycin for patients with acute exacerbation of fibrotic interstitial pneumonia